3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
8
Breast Neoplasms
7
Prostatic Neoplasms
6
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Urinary Bladder Neoplasms
5
Glioma
5
Astrocytoma
5
Oropharyngeal Neoplasms
4
Esophageal Neoplasms
4
Carcinoma
4
Burkitt Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Rectal Neoplasms
3
Neoplasm Metastasis
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Pancreatic Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Mesothelioma, Malignant
2
Melanoma
2
Liposarcoma
2
Laryngeal Neoplasms
2
Hodgkin Disease
2
Gliosarcoma
2
Ganglioneuroblastoma
2
Interventions
pembrolizumab
30
Paclitaxel
12
Carboplatin
10
Cisplatin
8
lenvatinib
7
Pemetrexed
5
belzutifan
4
Oxaliplatin
4
Gemcitabine
4
Fluorouracil
4
Capecitabine
4
patritumab deruxtecan
3
olaparib
3
Leucovorin
3
Albumin-Bound Paclitaxel
3
Acetaminophen
3
Levoleucovorin
2
Irinotecan
2
Histamine H2 Antagonists
2
Histamine Antagonists
2
Etoposide
2
Docetaxel
2
Dexamethasone
2
Cetuximab
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
zanidatamab
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Radiation
×
30 days
×
Clear all
No trials found.